Novozymes is headquartered in Bagsvaerd, Denmark.
Novozymes disclosed revenue of 17,899M DKK for 2023 and 17,553M DKK for 2022.
Novozymes has 6,397 employees.
Novozymes is a life science company.
Novozymes was founded in 1925.
Novozymes produces a wide range of industrial enzymes and microorganisms, providing innovative answers to some of the world’s most pressing challenges. Company innovative biological solutions improve industrial manufacturing processes by saving energy, water and raw materials, while reducing waste and emissions, and helping make everyday products more sustainable. Novozymes was founded in 1925 and is based in Bagsvaerd, Denmark.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 10 | - | - | - | - | - | 10 |
| vol | $485M | $485M | ||||||
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 10 | ||||||||
| Financial | Deals |
|---|---|
|
Achelous Partners |
2 |
|
C.W. Downer & Co. |
2 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
